Selected research
Market Outlook & Growth Opportunities
Global Industrial Hemp in Medical Market Outlook and Growth Opportunities 2026
Market perspective
The global Industrial Hemp in Medical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Industrial Hemp in Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Industrial Hemp in Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Industrial Hemp in Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Industrial Hemp in Medical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Industrial Hemp in Medical market include Zhejiang CONBA Pharmaceutical, Yunnan Industrial Hemp, Shanghai Shunho New Materials Technology, Kunming Longjin Pharmaceutical, Jinzhou Qiaopai Biotech, HMI Group, Dezhan Healthcare, CHENGZHI and Tilray, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Industrial Hemp in Medical market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Industrial Hemp in Medical and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Industrial Hemp in Medical sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Industrial Hemp in Medical market size, projected growth trends, production technologies, key applications, and end-use industries.
Industrial Hemp in Medical Segment by Company
Zhejiang CONBA Pharmaceutical
Yunnan Industrial Hemp
Shanghai Shunho New Materials Technology
Kunming Longjin Pharmaceutical
Jinzhou Qiaopai Biotech
HMI Group
Dezhan Healthcare
CHENGZHI
Tilray
Isodiol
HempFlax
Botanical Genetics
Boring Hemp
Industrial Hemp in Medical Segment by Type
Cannabinoid Groups
Non-Cannabinoid Groups
Industrial Hemp in Medical Segment by Application
Clinics
Hospitals
Medical Research Centers
Industrial Hemp in Medical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Industrial Hemp in Medical status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Industrial Hemp in Medical market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Industrial Hemp in Medical significant trends, drivers, influence factors in global and regions.
6. To analyze Industrial Hemp in Medical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Industrial Hemp in Medical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Industrial Hemp in Medical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Industrial Hemp in Medical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Industrial Hemp in Medical market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Industrial Hemp in Medical industry.
Chapter 3: Detailed analysis of Industrial Hemp in Medical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Industrial Hemp in Medical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Industrial Hemp in Medical in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Cannabinoid Groups
- Non-Cannabinoid Groups
Applications
- Clinics
- Hospitals
- Medical Research Centers
Companies covered
- Zhejiang CONBA Pharmaceutical
- Yunnan Industrial Hemp
- Shanghai Shunho New Materials Technology
- Kunming Longjin Pharmaceutical
- Jinzhou Qiaopai Biotech
- HMI Group
- Dezhan Healthcare
- CHENGZHI
- Tilray
- Isodiol
- HempFlax
- Botanical Genetics
- Boring Hemp
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Industrial Hemp in Medical Sales Value (2021-2032)
- 1.2.2 Global Industrial Hemp in Medical Sales Volume (2021-2032)
- 1.2.3 Global Industrial Hemp in Medical Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Industrial Hemp in Medical Market Dynamics
- 2.1 Industrial Hemp in Medical Industry Trends
- 2.2 Industrial Hemp in Medical Industry Drivers
- 2.3 Industrial Hemp in Medical Industry Opportunities and Challenges
- 2.4 Industrial Hemp in Medical Industry Restraints
3 Industrial Hemp in Medical Market by Company
- 3.1 Global Industrial Hemp in Medical Company Revenue Ranking in 2025
- 3.2 Global Industrial Hemp in Medical Revenue by Company (2021-2026)
- 3.3 Global Industrial Hemp in Medical Sales Volume by Company (2021-2026)
- 3.4 Global Industrial Hemp in Medical Average Price by Company (2021-2026)
- 3.5 Global Industrial Hemp in Medical Company Ranking (2024-2026)
- 3.6 Global Industrial Hemp in Medical Company Manufacturing Base and Headquarters
- 3.7 Global Industrial Hemp in Medical Company Product Type and Application
- 3.8 Global Industrial Hemp in Medical Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Industrial Hemp in Medical Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Industrial Hemp in Medical Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Industrial Hemp in Medical Market by Type
- 4.1 Industrial Hemp in Medical Type Introduction
- 4.1.1 Cannabinoid Groups
- 4.1.2 Non-Cannabinoid Groups
- 4.2 Global Industrial Hemp in Medical Sales Volume by Type
- 4.2.1 Global Industrial Hemp in Medical Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Industrial Hemp in Medical Sales Volume by Type (2021-2032)
- 4.2.3 Global Industrial Hemp in Medical Sales Volume Share by Type (2021-2032)
- 4.3 Global Industrial Hemp in Medical Sales Value by Type
- 4.3.1 Global Industrial Hemp in Medical Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Industrial Hemp in Medical Sales Value by Type (2021-2032)
- 4.3.3 Global Industrial Hemp in Medical Sales Value Share by Type (2021-2032)
5 Industrial Hemp in Medical Market by Application
- 5.1 Industrial Hemp in Medical Application Introduction
- 5.1.1 Clinics
- 5.1.2 Hospitals
- 5.1.3 Medical Research Centers
- 5.2 Global Industrial Hemp in Medical Sales Volume by Application
- 5.2.1 Global Industrial Hemp in Medical Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Industrial Hemp in Medical Sales Volume by Application (2021-2032)
- 5.2.3 Global Industrial Hemp in Medical Sales Volume Share by Application (2021-2032)
- 5.3 Global Industrial Hemp in Medical Sales Value by Application
- 5.3.1 Global Industrial Hemp in Medical Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Industrial Hemp in Medical Sales Value by Application (2021-2032)
- 5.3.3 Global Industrial Hemp in Medical Sales Value Share by Application (2021-2032)
6 Industrial Hemp in Medical Regional Sales and Value Analysis
- 6.1 Global Industrial Hemp in Medical Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Industrial Hemp in Medical Sales by Region (2021-2032)
- 6.2.1 Global Industrial Hemp in Medical Sales by Region: 2021-2026
- 6.2.2 Global Industrial Hemp in Medical Sales by Region (2027-2032)
- 6.3 Global Industrial Hemp in Medical Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Industrial Hemp in Medical Sales Value by Region (2021-2032)
- 6.4.1 Global Industrial Hemp in Medical Sales Value by Region: 2021-2026
- 6.4.2 Global Industrial Hemp in Medical Sales Value by Region (2027-2032)
- 6.5 Global Industrial Hemp in Medical Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Industrial Hemp in Medical Sales Value (2021-2032)
- 6.6.2 North America Industrial Hemp in Medical Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Industrial Hemp in Medical Sales Value (2021-2032)
- 6.7.2 Europe Industrial Hemp in Medical Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Industrial Hemp in Medical Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Industrial Hemp in Medical Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Industrial Hemp in Medical Sales Value (2021-2032)
- 6.9.2 South America Industrial Hemp in Medical Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Industrial Hemp in Medical Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Industrial Hemp in Medical Sales Value Share by Country, 2025 VS 2032
7 Industrial Hemp in Medical Country-level Sales and Value Analysis
- 7.1 Global Industrial Hemp in Medical Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Industrial Hemp in Medical Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Industrial Hemp in Medical Sales by Country (2021-2032)
- 7.3.1 Global Industrial Hemp in Medical Sales by Country (2021-2026)
- 7.3.2 Global Industrial Hemp in Medical Sales by Country (2027-2032)
- 7.4 Global Industrial Hemp in Medical Sales Value by Country (2021-2032)
- 7.4.1 Global Industrial Hemp in Medical Sales Value by Country (2021-2026)
- 7.4.2 Global Industrial Hemp in Medical Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.9.2 France Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.16.2 China Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.19.2 India Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Industrial Hemp in Medical Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Industrial Hemp in Medical Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Industrial Hemp in Medical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Zhejiang CONBA Pharmaceutical
- 8.1.1 Zhejiang CONBA Pharmaceutical Company Information
- 8.1.2 Zhejiang CONBA Pharmaceutical Business Overview
- 8.1.3 Zhejiang CONBA Pharmaceutical Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Zhejiang CONBA Pharmaceutical Industrial Hemp in Medical Product Portfolio
- 8.1.5 Zhejiang CONBA Pharmaceutical Recent Developments
- 8.2 Yunnan Industrial Hemp
- 8.2.1 Yunnan Industrial Hemp Company Information
- 8.2.2 Yunnan Industrial Hemp Business Overview
- 8.2.3 Yunnan Industrial Hemp Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Yunnan Industrial Hemp Industrial Hemp in Medical Product Portfolio
- 8.2.5 Yunnan Industrial Hemp Recent Developments
- 8.3 Shanghai Shunho New Materials Technology
- 8.3.1 Shanghai Shunho New Materials Technology Company Information
- 8.3.2 Shanghai Shunho New Materials Technology Business Overview
- 8.3.3 Shanghai Shunho New Materials Technology Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Shanghai Shunho New Materials Technology Industrial Hemp in Medical Product Portfolio
- 8.3.5 Shanghai Shunho New Materials Technology Recent Developments
- 8.4 Kunming Longjin Pharmaceutical
- 8.4.1 Kunming Longjin Pharmaceutical Company Information
- 8.4.2 Kunming Longjin Pharmaceutical Business Overview
- 8.4.3 Kunming Longjin Pharmaceutical Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Kunming Longjin Pharmaceutical Industrial Hemp in Medical Product Portfolio
- 8.4.5 Kunming Longjin Pharmaceutical Recent Developments
- 8.5 Jinzhou Qiaopai Biotech
- 8.5.1 Jinzhou Qiaopai Biotech Company Information
- 8.5.2 Jinzhou Qiaopai Biotech Business Overview
- 8.5.3 Jinzhou Qiaopai Biotech Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Jinzhou Qiaopai Biotech Industrial Hemp in Medical Product Portfolio
- 8.5.5 Jinzhou Qiaopai Biotech Recent Developments
- 8.6 HMI Group
- 8.6.1 HMI Group Company Information
- 8.6.2 HMI Group Business Overview
- 8.6.3 HMI Group Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.6.4 HMI Group Industrial Hemp in Medical Product Portfolio
- 8.6.5 HMI Group Recent Developments
- 8.7 Dezhan Healthcare
- 8.7.1 Dezhan Healthcare Company Information
- 8.7.2 Dezhan Healthcare Business Overview
- 8.7.3 Dezhan Healthcare Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Dezhan Healthcare Industrial Hemp in Medical Product Portfolio
- 8.7.5 Dezhan Healthcare Recent Developments
- 8.8 CHENGZHI
- 8.8.1 CHENGZHI Company Information
- 8.8.2 CHENGZHI Business Overview
- 8.8.3 CHENGZHI Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.8.4 CHENGZHI Industrial Hemp in Medical Product Portfolio
- 8.8.5 CHENGZHI Recent Developments
- 8.9 Tilray
- 8.9.1 Tilray Company Information
- 8.9.2 Tilray Business Overview
- 8.9.3 Tilray Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Tilray Industrial Hemp in Medical Product Portfolio
- 8.9.5 Tilray Recent Developments
- 8.10 Isodiol
- 8.10.1 Isodiol Company Information
- 8.10.2 Isodiol Business Overview
- 8.10.3 Isodiol Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Isodiol Industrial Hemp in Medical Product Portfolio
- 8.10.5 Isodiol Recent Developments
- 8.11 HempFlax
- 8.11.1 HempFlax Company Information
- 8.11.2 HempFlax Business Overview
- 8.11.3 HempFlax Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.11.4 HempFlax Industrial Hemp in Medical Product Portfolio
- 8.11.5 HempFlax Recent Developments
- 8.12 Botanical Genetics
- 8.12.1 Botanical Genetics Company Information
- 8.12.2 Botanical Genetics Business Overview
- 8.12.3 Botanical Genetics Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Botanical Genetics Industrial Hemp in Medical Product Portfolio
- 8.12.5 Botanical Genetics Recent Developments
- 8.13 Boring Hemp
- 8.13.1 Boring Hemp Company Information
- 8.13.2 Boring Hemp Business Overview
- 8.13.3 Boring Hemp Industrial Hemp in Medical Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Boring Hemp Industrial Hemp in Medical Product Portfolio
- 8.13.5 Boring Hemp Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Industrial Hemp in Medical Value Chain Analysis
- 9.1.1 Industrial Hemp in Medical Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Industrial Hemp in Medical Sales Mode & Process
- 9.2 Industrial Hemp in Medical Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Industrial Hemp in Medical Distributors
- 9.2.3 Industrial Hemp in Medical Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst